Interestingly, we find that the threshold used for NT-proBNP in this study is lower than the cut-points used in clinic and clinical trials for diagnosis of HF (<300 ng/L or < 400 ng/L less likely to be HF). This evidence concerns the gene NPPB and hydrops fetalis.